Business Wire

Tokyo Century Corporation and All Nippon Airways Trading Company to Acquire Significant Stake in GA Telesis

Del

GA Telesis, LLC (“GA Telesis” or “the Company”) announced today that its current shareholder Tokyo Century Corporation (“Tokyo Century”) along with All Nippon Airways Trading Company (“ANATC”)1, have collectively entered into a definitive agreement to acquire all shares held by Global Principal Finance Company LLC (“GPFC”)2.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180930005012/en/

Tokyo Century Corporation and All Nippon Airways Trading Company to Acquire Significant Stake in GA  ...

Tokyo Century Corporation and All Nippon Airways Trading Company to Acquire Significant Stake in GA Telesis. (Photo: Business Wire)

Tokyo Century’s ownership after the closing of the transaction will increase to 49.2% and ANATC will acquire a 10% interest in the Company. Tokyo Century and ANATC expect the transaction to close in October 2018.

Separately, GA Telesis, Tokyo Century and ANATC have reached an in-principle agreement to form a commercial engine leasing joint venture focusing on current technology jet engines. The equity will be provided by each party and the joint venture will be managed by GA Telesis.

The additional investment by Tokyo Century will bolster and further diversify Tokyo Century’s existing aviation investment platform, which also includes a 20% holding in Aviation Capital Group, the world’s premier aircraft leasing company, as well as a 16.7% position in Jetstar Japan.

"Our initial investment in GA Telesis from 2012 has performed well and proven our initial investment thesis," said Koichi Nakajima, Deputy President of Tokyo Century Corporation. "We have made a commitment to our customers and the industry to provide the best services in aviation. This further investment in the Company solidifies our strategy and promise.”

Established in 1970, ANATC has evolved from a service provider of aviation serviceable parts to a multinational service and solution provider that centers its business not only around aviation, but also in various fields such as food and beverages, electronics, and daily living essentials. Building on a strong customer base in Asia and other regions, ANATC strives to provide customer-centric and value-added solutions and services to its customers.

"This investment in GA Telesis is the next step in our growth strategy, with a clear opportunity to profitably grow our business and better serve our customers," said Hideto Osada, Senior Executive President of ANATC.

With approximately 600 employees worldwide, GA Telesis is headquartered in Ft. Lauderdale, Florida with financial services, sales, distribution operations and MRO services operations in more than 19 countries. As the leading independent provider of integrated solutions through the combination of financial services, used serviceable material supply-chain, major related MRO operations and other ancillary aftermarket services, GA Telesis continues to lead the industry by expanding the GA Telesis Ecosystem™ to include more product and service offerings to its customers.

“I am thrilled with Tokyo Century’s confidence in GA Telesis and decision to increase its stake in GA Telesis,” said Abdol Moabery, President & CEO of GA Telesis. “We have had a 15-year relationship with ANATC and their investment is not only a testament to the success of that relationship but also the innovative manner in which they view the future of the aviation marketplace. With these two great shareholders, I am confident that we will continue to deliver our year-on-year double-digit growth,” he added.

About Tokyo Century Corporation

Tokyo Century Corporation is a highly specialized and unique financial services company that pioneers new business fields combining finance, services and business expertise, working alongside customers in pursuit of their growth and goals. Through its four core businesses (Equipment Leasing, Specialty Financing, Domestic Automobile Financing, and International Business) Tokyo Century seeks to provide solutions that help increase the corporate value of customers.

About All Nippon Airways Trading Company

ANATC is a global solution and service provider, focusing in five business areas: retail, digital marketing, food, aerospace and electronics, and lifestyle businesses. ANATC headquartered in Tokyo, Japan, has business units in France and Singapore, and 11 group companies, with a multinational workforce of approximately 2,300 people.

About GA Telesis

GA Telesis is a global leader providing integrated solutions to the aviation and aerospace industries. Built on the premise of “Customer Success” being the goal, GA Telesis serves over 3,000 customers including airlines, OEMs, MROs and suppliers worldwide with 31 leasing, sales, distribution and MRO operations in 19 countries. At GA Telesis the company’s core business is integrated aviation solutions and their mission is customer success.

1 ANATC is a wholly owned subsidiary of ANA Holdings

2 Global Principal Finance Company LLC is a wholly owned subsidiary of Bank of America Corporation

Contact information

GA Telesis, LLC
Cathy Moabery, 954-676-3111 Ext. 2238
cmoabery@gatelesis.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Boehringer Ingelheim and OSE Immunotherapeutics Announce Dosing Of the First Patient in a Phase 1 Trial of SIRPα Antagonist Monoclonal Antibody, BI 765063, in Patients with Advanced Solid Tumors17.6.2019 16:00:00 CESTPressemelding

Boehringer Ingelheim and OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) today announce that the first patient has been dosed in the first-in-human Phase 1 clinical trial evaluating BI 765063, formerly OSE-172, a first-in-class monoclonal antibody antagonist of SIRPα, being studied in patients with advanced solid tumors. The Phase 1 study is a dose finding study of BI 765063, a myeloid checkpoint inhibitor, administered as a single agent and in combination with Boehringer Ingelheim’s monoclonal antibody PD-1 antagonist BI 754091, a T-lymphocyte checkpoint inhibitor. “We are very pleased with the progress achieved on BI 765063’s program and having the first patient dosed marks a significant milestone in the product’s development. The advancement of a myeloid cell checkpoint blocking monoclonal antibody into the clinic exemplifies Boehringer Ingelheim’s commitment to the next wave of innovation in cancer immunology therapies, with the goal of meaningfully improving outcomes fo

MagicStay Raises €3 Million to Accelerate Its International Development17.6.2019 15:58:00 CESTPressemelding

The apartment rental platform dedicated to business travelers, MagicStay.com , announces its full integration into the main business travel booking tools and a €3 million A-series to pursue its development, bringing the amounts raised to more than €8 million since its launch in 2013. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005644/en/ William Lecerf and Valéry Linyer, co-founders of MagicStay (Photo: MagicStay) "This fundraising will allow us to recruit talent to accelerate our growth. We want to sign a quarter of the major French companies and approach one million homes before the end of the year, thanks to the exclusive technologies we now have at our disposal", says Valéry Linÿer, CEO and co-founder, who adds: "We have four main advantages over our competitors: we meet the challenges of duty of care, we are able to customize our tool to meet the constraints of each large company for short and long stays, we ha

EURid Shows a 94% Reduction of Its Footprint since 201217.6.2019 15:32:00 CESTPressemelding

EURid, the not-for-profit organisation that operates the .eu and .ею top-level domains, is the first European TLD registry that registered for the EU Eco-Management and Audit Scheme (EMAS) from 2011. Since then, EURid has regularly assessed the environmental impact of its activities and monitored the compliance of its policies and procedures. As over the past four years, in Q2 2019 EURid was audited for the CO2 emissions of the previous year, resulting in an overall footprint of 135 tons CO2eq, which shows a 94% reduction since 2012. “We have achieved carbon neutrality via several actions and the compensation of the audited emissions. We were and are still among the first in our sector to report on our commitment to protect the environment”, commented CEO Marc Van Wesemael. Through EMAS, EURid has had the opportunity to support a multitude of global sustainability initiatives, like the Ugandan Borehole Project, Ecomapuà Project in the Amazon, the Dak Rung Hydropower Project in Vietnam,

Animation, Sound & Vibration – How Visa is Reinforcing Consumer Trust in a Changing Payments World17.6.2019 15:00:00 CESTPressemelding

Visa (NYSE: V) today announced global adoption of its sensory branding suite in 25 countries via more than a dozen new partnerships. The suite is comprised of sound, animation and haptic brand cues that occur with a Visa payment transaction. In a digital world increasingly filled with voice-commands, networked appliances and unattended retail environments, Visa’s sensory branding cues offer new ways to enhance the customer experience and convey the trust and security that the Visa brand represents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005240/en/ Visa was the first major payment brand to introduce multi-sensory branding, which included animation, sound and haptic vibration expressions of its brand. After an extensive creation and selection process that involved focus groups and elimination rounds, Visa landed on a single ‘energetic’ and ‘optimistic’ sound, and complementary animation and haptic vibration. Sinc

Study from Project Management Institute Identifies Six AI Technologies Impacting Project Professionals17.6.2019 14:40:00 CESTPressemelding

Project Management Institute (PMI) today released its 2019 Pulse of the Profession® In-Depth Report: AI Innovators: Cracking the Code on Project Performance. The report provides an in-depth look at how artificial intelligence (AI) is impacting organizations and the project management profession. Findings reveal that AI disruption is happening and at a large scale: 81 percent of respondents report their organization is being impacted by AI technologies; 37 percent say adopting AI technologies is a high priority for their organization; and project professionals say they expect the proportion of the projects they manage using AI will jump from 23 to 37 percent over the next three years. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005558/en/ These insights from a survey of 551 project management practitioners globally show that the presence of AI technologies will continue to grow, requiring shifts in how projects are m

RIBOMIC Announces Positive Top-Line Results from the Phase 1/2a Clinical Trial of RBM-007 (SUSHI Study) in Subjects with Wet Age-Related Macular Degeneration17.6.2019 13:15:00 CESTPressemelding

RIBOMIC, Inc., a clinical stage pharmaceutical company specializing in aptamer therapeutics and traded on the Mothers Market of the Tokyo Stock Exchange (Code Number: 4591), today announced positive top-line results from its SUSHI study, Phase 1/2a single ascending dose clinical study of RBM-007, anti-FGF2 aptamer, in nine subjects with wet Age-Related Macular Degeneration (wet AMD). SUSHI study achieved the primary endpoint of safety and tolerability, and also demonstrated efficacy trends in favor of RBM-007. Subjects recruited for the SUSHI Study had wet AMD that was poorly responsive to previous intravitreal anti-VEGF therapy. Through the 56-Day exit visit, excluding one uncompleted case in the last cohort, single dose of RBM-007 demonstrated no dose-limiting toxicities, no systemic or ocular serious adverse events. One subject in Cohort 3 showed anterior inflammation, which was resolved after one day of topical prednisolone treatment. Rescue treatment with anti-VEGF therapy was ava